A start-up company is aiming to help pharmaceutical professionals by helping them communicate through the use of an online educational
Breaking News
- Brexit – Implications For the Pharma Industry in Ireland The UK’s referendum decision to leave the EU in May 2016 undoubtedly sent shockwaves throughout Europe. European countries are still struggling to interpret what ‘Brexit’ will mean for them. Ireland,...
- EMA to Work With Stakeholders to Improve Product Information For EU Medicines The European Medicines Agency (EMA) has published an action plan to improve the product information (PI) for EU medicines, an information package for patients and healthcare professionals that accompanies every single medicine authorised in...
- Diaceutics Wins at Export Industry Awards Diaceutics, the Irish data insights and solutions company helping patients receive potentially lifesaving medicine through better testing, won the Small & Emerging Exporter of the Year Award at the recent Export...
- Brexit – Key Issues For the Pharmaceutical Industry Brexit – the stark reality is that the UK’s EU membership and the application of all EU legislation in the UK ends automatically at midnight on 30th March 2019! Current understanding...
- European Commission Diagnoses the State of Health in the EU Only by rethinking our health systems can we ensure that they remain fit-for-purpose and provide patient-centred care. This is what the 28 Country Health Profiles recently published by the Commission,...
The Museum of the History of Science in Oxford is hosting an exhibition on the history of penicillin and the
A medical team from Clínica Universidad de Navarra in Pamplona has successfully performed Spain’s first implant of the SynCardia temporary
Frost & Sullivan, Gary Jeffery comments on the implications of Brexit for businesses both in and out of the UK.
Healthcare giant Johnson & Johnson is planning to close its medical manufacturing plant in West Lothian, Scotland, potentially affecting around
SenzaGen and AstraZeneca will develop a new genomic signature to distinguish allergens from irritants in the respiratory tract Swedish in
An epidemiological study published in Frontiers in Oncology suggests that a diet high in carotenoids and vitamin C may protect
Innovus Pharmaceuticals, Inc., an emerging over-the-counter consumer goods and specialty pharmaceutical company engaged in the commercialization, licensing and development of
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company focused on developing gene therapies for life-threatening rare diseases, announced today that the
Score one for Samsung Bioepis in its quest to bring a biosimilar version of AbbVie’s anti-inflammatory behemoth Humira to market in
In an editorial published in the journal ecancermedicalscience, leading academics from across the UK explore the risks facing cancer care,
Italy adopts gender-neutral HPV vaccination program, citing study by health economics expert from Kingston University London’s Business School. The Italian
Medical device company Olberon has developed a product to help doctors and nurses insert needles into patients’ blood. Olberon states
The National Institute for Health and Care Excellence (NICE) is half way through a review of drugs approved and still
A survey conducted by Fortune determined that the company are most admired by peers out of all the pharma companies
Regulators on both sides of the Atlantic are reviewing three new submissions for medicines containing ertugliflozin, an investigational SGLT2 inhibitor
Actelion has received approval from the European Commission for Ledaga, a treatment to prevent the progression of a rare form
A new method to help diagnose oesophageal cancer is being researched by engineers and physicians at the Institute of Biological
Advertisements
